OTHERClinicalTrials.govClinical trialCompleted
Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy
Official record
- Identifier
NCT02441153- Recruiting locations
- Locations are not included in the offline baseline for this record. Open the official record to see the current site list.
- Interventions studied
- Extended Timing
- Lead sponsor
- Health Sciences North Research Institute
- Target enrolment
- 50 participants
- Study type
- OBSERVATIONAL
- Phase
- Not provided in the official record
- Status
- Completed
- First posted
- May 12, 2015
- Last updated on the registry
- Oct 1, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- No public contact is listed on the official record.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Adult patients (\>18 years) * T3/4N0M0 or TxN+M0 rectal cancer below or at the peritoneal reflection, confirmed on clinical exam, histology, pelvic MRI, and CT chest/abdo * Patients who have completed a CRT protocol for the above tumor at HSN * Informed consent given * Surgical resection with TME planned Exclusion Criteria: * Metastatic disease * Failure to complete preoperative CRT * Unable to give free and informed consent * Unable to comply with the requirements of the study * Previous malignancy other than nonmelanoma skin cancer, papillary or follicular thyroid cancer * Inflammatory bowel disease * Hereditary colorectal cancer
- Indexed under
- Colorectal Cancer